Aclarion, Inc. (ACON)
NASDAQ: ACON · IEX Real-Time Price · USD
0.294
-0.007 (-2.19%)
Jul 17, 2024, 4:00 PM EDT - Market closed

Company Description

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States.

It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.

The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021.

Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Aclarion, Inc.
Aclarion logo
Country United States
Founded 2008
IPO Date Apr 22, 2022
Industry Health Information Services
Sector Healthcare
Employees 4
CEO Brent Ness

Contact Details

Address:
8181 Arista Place, Ste 100
Broomfield, Colorado 80021
United States
Phone 833 275 2266
Website aclarion.com

Stock Details

Ticker Symbol ACON
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $4.35
CIK Code 0001635077
CUSIP Number 655187102
ISIN Number US6551872012
Employer ID 47-3324725
SIC Code 8071

Key Executives

Name Position
Brent Ness Chief Executive Officer, President and Director
Dr. Jeffrey John Thramann M.D. Executive Chairman
John Lorbiecki Chief Financial Officer
Ryan Bond Chief Strategy Officer

Latest SEC Filings

Date Type Title
Jun 26, 2024 8-K Current Report
Jun 24, 2024 QUALIF Filing
Jun 20, 2024 1-A/A Filing
Jun 18, 2024 8-K Current Report
Jun 11, 2024 1-A Filing
May 15, 2024 10-Q Quarterly Report
Apr 29, 2024 8-K Current Report
Apr 12, 2024 8-K Current Report
Mar 29, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Mar 28, 2024 10-K Annual Report